Calendar

TFF Pharmaceuticals Announces Update on Clinical Programs

Retrieved on: 
Wednesday, March 20, 2024

FORT WORTH, Texas, March 20, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, is announcing data updates and strategic prioritization of its clinical programs. Based on positive data from the ongoing Phase 2 study of TFF TAC, the potential to address a significant unmet need in lung transplant medicine, and substantial market opportunity, the Company has made the decision to prioritize the TFF TAC program and focus resources on the acceleration of its clinical pathway towards registration.

Key Points: 
  • “However, after a rigorous assessment of our pipeline, including the significant capital and resources required to progress both clinical development programs, we will focus our clinical development efforts and financial resources on TFF TAC.
  • In summary, for TFF TAC, eight out of eight patients have successfully transitioned from oral Tacrolimus to TFF TAC in the Phase 2 study.
  • TFF TAC continues to demonstrate favorable safety results with no mortality or discontinuations due to adverse events.
  • The Company will host a conference call on Wednesday, March 27, 2024, at 4:30 PM Eastern Time, to discuss updated clinical data for the TFF TAC and TFF VORI.

Kingsoft Cloud Announces Unaudited Fourth Quarter and Fiscal Year 2023 Financial Results

Retrieved on: 
Wednesday, March 20, 2024

BEIJING, March 20, 2024 (GLOBE NEWSWIRE) -- Kingsoft Cloud Holdings Limited (“Kingsoft Cloud” or the “Company”) (NASDAQ: KC and HKEX: 3896), a leading independent cloud service provider in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023.

Key Points: 
  • BEIJING, March 20, 2024 (GLOBE NEWSWIRE) -- Kingsoft Cloud Holdings Limited (“Kingsoft Cloud” or the “Company”) (NASDAQ: KC and HKEX: 3896), a leading independent cloud service provider in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023.
  • Mr. Tao Zou, Chief Executive Officer of Kingsoft Cloud, commented, “In 2023, we continued to uphold the principle of high-quality and sustainable development and have accomplished significant achievements.
  • Revenues from public cloud services increased by 3.5% from RMB1,016.6 million in last quarter to RMB1,052.0 million (US$148.2 million).
  • Revenues from public cloud services decreased by 21.7%, compared with RMB1,344.3 million in the same quarter of 2022.

Great Southern Bancorp, Inc. announces quarterly dividend of $0.40 per common share

Retrieved on: 
Wednesday, March 20, 2024

SPRINGFIELD, Mo., March 20, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Great Southern Bancorp, Inc. (NASDAQ:GSBC), the holding company for Great Southern Bank, declared a $0.40 per common share dividend for the first quarter of the calendar year ending December 31, 2024.

Key Points: 
  • SPRINGFIELD, Mo., March 20, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Great Southern Bancorp, Inc. (NASDAQ:GSBC), the holding company for Great Southern Bank, declared a $0.40 per common share dividend for the first quarter of the calendar year ending December 31, 2024.
  • This dividend represents the 137th consecutive quarterly dividend paid by the Company to common stockholders.
  • With total assets of $5.8 billion, Great Southern offers a broad range of banking services to commercial and consumer customers.
  • Great Southern Bancorp is a public company and its common stock (ticker: GSBC) is listed on the NASDAQ Global Select Market.

Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes

Retrieved on: 
Wednesday, March 20, 2024

CHASKA, Minn., March 20, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that its Board of Directors unanimously approved the conclusion of its review of strategic alternatives that was initiated in March 2023, and, concurrently therewith, announced several strategic updates related to its operations on a stand-alone basis.

Key Points: 
  • This conclusion was based on an expansive strategic review process, including outreach to and engagement with over 75 buyers, including both strategic buyers and financial sponsors.
  • “The Board of Directors appreciates all of the hard work put into the strategic review process by the Company and its advisors.
  • The Board looks forward to working with the management team to lead the Company’s execution on its strategic plan,” said Craig Barbarosh, Chairman of the Board.
  • With these investments, Lifecore believes it is positioned for substantial growth as its additional aseptic capacity becomes available.

Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q

Retrieved on: 
Wednesday, March 20, 2024

The Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the “SEC”).

Key Points: 
  • The Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the “SEC”).
  • Under Nasdaq rules, the company has 60 calendar days from the receipt of the Notice, or until May 20, 2024, to submit a plan to regain compliance with the Rule.
  • The company intends to file the Form 10-Q as promptly as reasonably practicable.
  • If the company does not file the Form 10-Q by May 20, 2024, the company intends to timely submit a plan to regain compliance with the Rule.

Sunrise Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement

Retrieved on: 
Wednesday, March 20, 2024

ZIBO, China, March 19, 2024 (GLOBE NEWSWIRE) -- Sunrise New Energy Co., Ltd. (“Sunrise”, the “Company”, “we” or “our”) (NASDAQ: EPOW), today announced that it has received a letter (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on March 14, 2024, notifying the Company that it no longer meets the minimum bid price requirement set forth in the Nasdaq Listing Rules.

Key Points: 
  • ZIBO, China, March 19, 2024 (GLOBE NEWSWIRE) -- Sunrise New Energy Co., Ltd. (“Sunrise”, the “Company”, “we” or “our”) (NASDAQ: EPOW), today announced that it has received a letter (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on March 14, 2024, notifying the Company that it no longer meets the minimum bid price requirement set forth in the Nasdaq Listing Rules.
  • Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of US$1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days.
  • Based on the closing bid price of the Company's Class A ordinary shares for the 30 consecutive business days from January 30, 2024 to March 14, 2024, the Company no longer meets the minimum bid price requirement.
  • The Company intends to monitor the closing bid price of its Class A ordinary shares and may, if appropriate, consider implementing available options to regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules.

Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024

Retrieved on: 
Tuesday, March 19, 2024

Upon registration, a dial-in number and unique PIN will be provided to join the call.

Key Points: 
  • Upon registration, a dial-in number and unique PIN will be provided to join the call.
  • To access the live webcast link, log onto www.fennepharma.com and proceed to the News & Events / Event Calendar page under the Investors & Media heading.
  • Please connect to the company’s website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to listen to the webcast.
  • A webcast replay of the conference call will also be archived on www.fennecpharma.com for thirty days.

Rego Payment Architectures, Inc. Secures Extension of $20 Million Line of Credit

Retrieved on: 
Tuesday, March 19, 2024

BLUE BELL, Pa., March 19, 2024 (GLOBE NEWSWIRE) -- Rego Payment Architectures, Inc. (“REGO”) (OTCQB: RPMT), today announced it has secured an amendment to its $20 million line of credit (“LOC”) from one of its major investors, Mr. James Davison.

Key Points: 
  • BLUE BELL, Pa., March 19, 2024 (GLOBE NEWSWIRE) -- Rego Payment Architectures, Inc. (“REGO”) (OTCQB: RPMT), today announced it has secured an amendment to its $20 million line of credit (“LOC”) from one of its major investors, Mr. James Davison.
  • This amendment extends the LOC until March 13, 2025.
  • Peter S. Pelullo, Chief Executive Officer at REGO, said, “This extension positions and solidifies the company’s ability to execute our strategic planning activities for 2024.
  • Banks and credit unions are now looking to FinTech providers like REGO, who can deliver a unique, one-of-a-kind offering that is COPPA & GDPR compliant, for their family wallet solutions.

Coda Octopus Group Reports Fiscal First Quarter 2024 Financial Results

Retrieved on: 
Monday, March 18, 2024

ORLANDO, FL, March 18, 2024 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. (“CODA” or the “Company”) (Nasdaq: CODA), a global market leader in 3D/4D/5D/6D imaging sonar technology for real time subsea intelligence and cutting-edge diving technology, today reported its unaudited financial results for its fiscal first quarter ended January 31, 2024 (FQ2024).

Key Points: 
  • ORLANDO, FL, March 18, 2024 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. (“CODA” or the “Company”) (Nasdaq: CODA), a global market leader in 3D/4D/5D/6D imaging sonar technology for real time subsea intelligence and cutting-edge diving technology, today reported its unaudited financial results for its fiscal first quarter ended January 31, 2024 (FQ2024).
  • Annmarie Gayle, CODA’s Chairman and CEO, commented: “Our First Quarter 2024 results were in alignment with our internal Business Plan but down compared to our First Quarter 2023.

  • The Company’s full financial results, including its Quarterly Report for the First Quarter of 2024, are available at www.nasdaq.com/symbol/coda/sec-filings .
  • CODA will host a conference call today, March 18, 2024, at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time) to discuss its results for the First Quarter ended January 31, 2024.

Home BancShares, Inc. Announces First Quarter Earnings Release Date and Conference Call

Retrieved on: 
Monday, March 18, 2024

Following this release, management will conduct a conference call to review these earnings at 1:00 p.m. CT (2:00 p.m.

Key Points: 
  • Following this release, management will conduct a conference call to review these earnings at 1:00 p.m. CT (2:00 p.m.
  • We strongly encourage all participants to pre-register for the conference call webcast or the live call using one of the following links.
  • First, participants can pre-register for the conference call webcast using the following link: https://events.q4inc.com/attendee/645372014 .
  • Participants who pre-register will be given a unique webcast link to gain immediate access to the conference call webcast.